News
02-04-2011, 05:35 AM
Merck, known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the fourth quarter of $0.88, which excludes purchase accounting adjustments, restructuring costs and merger-related expenses.
More... (http://www.news-medical.net/news/20110204/Merck-reports-GAAP-net-income-of-24861-million-for-2010.aspx)
More... (http://www.news-medical.net/news/20110204/Merck-reports-GAAP-net-income-of-24861-million-for-2010.aspx)